Company / AR per Share
Bristol Myers Squibb AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$4.62
FY2025
5-year range
$3.61 / $4.66
FY2021-FY2025
Trend
+9.9%
vs FY2024
Sector context
#22 of 113
Health Care
What the data says
Bristol Myers Squibb's ar per share of $4.62 is higher than 81% of companies in the Health Care sector (FY2025). AR per Share has increased for 3 consecutive years, from $3.61 in FY2022 to $4.62 in FY2025.
Based on SEC 10-K filings.
4.62 in FY2025 with a 5-year CAGR of +0.9%. Top quartile in the Health Care sector.
Improved from $3.96 to $4.62 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +8.5%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 113This company $4.62 Sector average $28.83
▼
-84.0% below sector average
Key checks
Key Insights
- Bristol Myers Squibb's ar per share has grown for 3 consecutive years.
- In FY2025, ar per share increased 9.9% year-over-year.
- Ranks #22 out of 113 companies in the Health Care sector.
- Peak ar per share was recorded in FY2021.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.85 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
- Strong return on equity: 32.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.62 | +9.9% |
| FY2024 | $4.20 | +6.1% |
| FY2023 | $3.96 | +9.6% |
| FY2022 | $3.61 | -22.5% |
| FY2021 | $4.66 | +5.7% |
| FY2020 | $4.41 | +12.5% |
| FY2019 | $3.92 | +42.1% |
| FY2018 | $2.76 | +6.6% |
| FY2017 | $2.59 | +14.6% |
| FY2016 | $2.26 | +27.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026